Evolution Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-10,000
| Closed | -$88.5K | – | 123 |
|
2023
Q1 | $88.5K | Buy |
+10,000
| New | +$88.5K | 0.02% | 114 |
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$81K | – | 126 |
|
2022
Q3 | $81K | Hold |
10,000
| – | – | 0.02% | 106 |
|
2022
Q2 | $75K | Hold |
10,000
| – | – | 0.02% | 112 |
|
2022
Q1 | $94K | Buy |
+10,000
| New | +$94K | 0.02% | 118 |
|
2021
Q4 | – | Sell |
-230
| Closed | -$2K | – | 578 |
|
2021
Q3 | $2K | Hold |
230
| – | – | ﹤0.01% | 655 |
|
2021
Q2 | $2K | Hold |
230
| – | – | ﹤0.01% | 623 |
|
2021
Q1 | $3K | Hold |
230
| – | – | ﹤0.01% | 614 |
|
2020
Q4 | $2K | Hold |
230
| – | – | ﹤0.01% | 566 |
|
2020
Q3 | $2K | Hold |
230
| – | – | ﹤0.01% | 566 |
|
2020
Q2 | $3K | Hold |
230
| – | – | ﹤0.01% | 451 |
|
2020
Q1 | $2K | Sell |
230
-582
| -72% | -$5.06K | ﹤0.01% | 296 |
|
2019
Q4 | $8K | Buy |
+812
| New | +$8K | ﹤0.01% | 340 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 485 |
|
2019
Q1 | – | Sell |
-50
| Closed | -$1K | – | 149 |
|
2018
Q4 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 139 |
|